Since MDSCs can release immunosuppressive factors, e.g., IL-10 and tumor growth factor (TGF)-β, augment inhibitory immune checkpoint signaling, and inhibit NK cell-mediated antitumoral immune responses, they pave the way for the immune evasion of the HCC cells [32]. This evidence concerns the gene IL10 and hepatocellular carcinoma.